[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"intestinal-functional-disorder\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:intestinal-functional-disorder":43},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":29,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":5},"100603349",false,"NCT07135362","The Efficacy Evaluation of TCI604 Probiotic on Intestinal Function Improvement","The Efficacy Evaluation of Bifidobacterium Animalis Subsp. Lactis TCI604 Probiotic on Intestinal Function Improvement","Inclusion Criteria:\n\n* Male or non-pregnant female subjects aged 18 to 65 who are willing to sign the informed consent form;\n* Diagnosed with functional constipation as assessed by a physician;\n* Non-pregnant females who agree to use physical contraceptive methods during the study period (e.g., condoms, intrauterine devices);\n* No history of organ transplantation, epilepsy or seizures, liver or kidney disease, malignancy, psychiatric disorders, alcohol or drug abuse, or other major organic diseases (as determined by medical history).\n\nExclusion Criteria:\n\n* Use of probiotics, gastrointestinal health supplements, medications, or antibiotics within 30 days prior to the study;\n* Presence of chronic gastrointestinal diseases (e.g., irritable bowel syndrome \\[IBS\\], inflammatory bowel disease \\[IBD\\], Crohn's disease, celiac disease, bowel control problems\u002Ffecal incontinence, pancreatitis, peptic ulcers, colorectal cancer, short bowel syndrome, ulcerative colitis);\n* History of gastrointestinal or major surgery;\n* Lactose intolerance;\n* Chronic diarrhea;\n* Pregnant or breastfeeding women;\n* Known allergy to any components of the study product.",true,"ALL","18 Years","65 Years",{"count":20,"type":21},60,"ESTIMATED","INTERVENTIONAL",[24],"NA","The objective of this study is to evaluate whether the TCI604 probiotics has the potential to enhance human gut function and alleviate constipation.",[27,28],"Constipation","Intestinal Functional Disorder",[30],"Bifidobacterium animalis subsp. lactis","RECRUITING","2025-08-18",{"date":34,"type":35},"2025-08-22","ACTUAL",{"date":37,"type":35},"2025-08-11",{"date":39,"type":21},"2026-07-31",{"name":41,"class":42},"TCI Co., Ltd.","INDUSTRY",""]